Beckman Coulter
Laboratory automation technology, centrifuges, blood analyser, diagnostics, non-photolithography produced DNA arrays
Beckman Coulter was formed upon the acquisition of Coulter Corp. by Beckman Instruments
Scott Garrett (CEO)
James T. Glover (CFO)
4300 N. Harbor Boulevard
P.O. Box 3100
Fullerton, CA 92834-3100
USA
Phone: +1-800-742-2345
Fax: +1-800-643-4366
A2 MicroArray™ platform
Related patents
Related news
- Beckman Coulter's 4th Quarter and Full Year 2007 Revenue Grows 10.8% and 9.2%, Respectively; 2007 Earnings Per Share Beat Outlook
- Beckman Coulter to Acquire Exclusive Rights to Breakthrough Technologies
- Beckman Coulter Announces Third Quarter 2007 Results
- Beckman Coulter Announces Licensing Option Agreements for Cancer Genes With Johns Hopkins University
- Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years
- Expanded Beckman Coulter eStore Streamlines Instruments, Reagents and Consumables Purchasing
- Beckman Coulter Advises It Will Not Increase Its Offer to Acquire Biosite Beyond $90.00 Per Share
- Beckman Coulter Launches the UniCel® DxI 600, Targeted to Mid-Volume Labs
- Biosite and Beckman Coulter Amend Definitive Merger Agreement
- Beckman Coulter Acknowledges Receipt of Notice From Biosite
- Beckman Coulter Proposed Acquisition of Biosite Passes Milestone with U.S. Regulatory Approval
- Beckman Coulter Reaffirms Commitment to Acquire Biosite
- Beckman Coulter to Acquire Biosite Incorporated
- Beckman Coulter Announces Exercise of Overallotment Option for Convertible Senior Notes
- Anti-Osteoclast-Associated Receptor (OSCAR)-PE RUO Monoclonal Antibody Expands Study of Dendritic Cell Function
- Agencourt® RNAdvance™ Tissue System Delivers Higher Yields For Gene Expression Studies
- Beckman Coulter’s Genetic Analysis System Helps Screen Brain Tumour Samples and Target Chemotherapy
- New System Automates Nucleic Acid Extraction from FFPE Tissue Samples
- Beckman Coulter Announces First Quarter 2006 Results, Confirms Continued Progress on Key Initiatives and Raises Full Year Outlook
- Beckman Coulter Announces Enhancements to its Top-of-the-Line Liquid Handlers
- Beckman Coulter to Launch New SNPStart Kit That Multiplexes 10 SNPs in a Single Tube
- New CD136 (RON)-PE RUO Monoclonal Antibody Identifies Potential Marker of Epithelial Cells
- New CD136 (RON)-PE RUO Monoclonal Antibody Identifies Potential Marker of Epithelial Cells
- Beckman Coulter Announces Management Change
- Beckman Coulter Expands Proteome Partitioning Chemistry Line for Biomarker Discovery